Atlas Trials

To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames

Clinical trial NCT03975205 · UNKNOWN

Trial details

NCT number
NCT03975205
Sponsor
Sutphin Drugs
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Lymphoma Leukemia
Start date
2019-07-01
Primary completion
2019-10-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.